Science for the protection of consumers

BfR publishes its Annual Report for 2008

26-Aug-2009 - Germany

Do toner particles pose a threat to health? Does dioxin in pork constitute a risk for consumers? Can fragrances trigger allergies? The Federal Institute for Risk Assessment (BfR) assesses risks from many areas of daily life. They include things like chemicals as well as food of plant and animal origin, cosmetics and children’s toys. Faithful to the motto "Avoid crises before they happen", around 700 staff members at the Institute’s three locations in Berlin work on consumer health protection in Germany and Europe. The Institute presents information on the results of its work last year in its 2008 Annual Report. "In 2008 none of the problems in the field of consumer health protection developed into a full blown crisis," says BfR President Professor Dr. Dr. Andreas Hensel. "BfR made a major contribution to this positive situation through its scientific expertise and transparent work."

One chapter in the BfR Annual Report is dedicated to the main areas covered last year. They include the final assessment of the “Toner Study“. According to this study, health impairments caused by emissions from laser printers and photocopiers cannot be ruled out because – given their operating mode – the chemical and physical processes involved lead to further contamination of indoor air. However, most of the emitted particles are not toner particles. There is a need for research to establish the chemical and physical identity of the particles measured. Furthermore, in 2008 BfR scientists turned their attention to the assessment of long-lived organic contaminants that can accumulate in the food chain. In the case of the industrial chemicals perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) they came to the conclusion that, based on the latest scientific findings available, a health risk arising from the intake of the levels of these chemicals detected up to now in food like, for instance, fish is unlikely. Nevertheless, every effort should be made to reduce these levels in food.

Background information on the main topics and further details of the assessment and research activities of all departments of the Federal Institute for Risk Assessment are provided in the new 78-page Annual Report. The Departments for Risk Communication, Scientific Services, Biological Safety, Food Safety, Safety of Substances and Preparations and Safety of Consumer Products report on the projects they were involved in last year.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

New biomarkers for coffee consumption

New biomarkers for coffee consumption

Laboratory equipment specialist KNAUER wanted to help save the world and now received German Innovation Award

Laboratory equipment specialist KNAUER wanted to help save the world and now received German Innovation Award

Combining therapies appears safe, may benefit patients with advanced liver cancer, UF scientists say

The future of personalized cancer treatment: An entirely new direction for RNAi delivery

The future of personalized cancer treatment: An entirely new direction for RNAi delivery

Proven for the First Time: The Microbiome of Fruit and Vegetables Positively Influences Diversity in the Gut - Bacterial diversity in the gut plays an important role in human health

Proven for the First Time: The Microbiome of Fruit and Vegetables Positively Influences Diversity in the Gut - Bacterial diversity in the gut plays an important role in human health

Protein interactions: who is partying with whom and who is ruining the party? - New method for investigating protein interaction networks - also of interest for pharmaceutical research

Protein interactions: who is partying with whom and who is ruining the party? - New method for investigating protein interaction networks - also of interest for pharmaceutical research

Researchers identify phosphorylation process vital to cancer growth

Ebola virus disarmed by excising a single gene

A novel human stem cell-based model of ALS opens doors for rapid drug screening

Dr. Roland Durner becomes new CEO of Bioengineering AG

Dr. Roland Durner becomes new CEO of Bioengineering AG

Biosciences' Nimotuzumab Selected for Multinational Phase III Trial by National Cancer Centre of Singapore - Singapore investigators to coordinate 700 patient trial of EGFR targeting antibody for treatment of head and neck cancer

Consortium lead by Prophylix Pharma AS receives up to €6 M in EU-funding - The EU grant is for development of a prophylactic treatment to prevent severe bleeding and death in newborns caused by Fetal/Neonatal Alloimmune Trombocytopenia